PR Newswire: The Heart & Vascular Center of Arizona today announced the availability of Corus(TM) CAD, the first and only gene expression test to quantify the likelihood of obstructive(i) coronary artery disease (CAD) in patients with stable chest pain.

GenomeWeb: While several competing sequencing platforms are focusing on large numbers of reads and low cost per base, PacBio is initially emphasizing the comparatively long read lengths, short run time, low cost per experiment, and different applications that its single-molecule analysis system will provide.

Reuters: Sabrix, based in San Ramon, California, makes software that helps companies process sales and use taxes, as well as value-added taxes (VAT) and other kinds of transaction taxes, in 170 countries.